Uniseed began as a $20 million venture fund, founded by the Universities of Queensland and Melbourne. Since then, through investment commitment from Westscheme, Western Australia's largest non-government superannuation fund, the University of New South Wales and further investment from the founding Universities, the fund has grown to over $60 million.

Uniseed has a commitment to successfully commercialise the outcomes of Australian research and ingenuity from the University of Queensland, the University of Melbourne and the University of New South Wales.

It represents an important step in forging a link between academia and business that focuses on the commercialisation of innovative ideas and inventions for global consumption.

Uniseed has strong capabilities to package research outcomes from the academic research environment.

 

Verva Announces AUD 2m Financing and Results of Annual General Meeting
(Media Release, 12 June 2009)

Uniseed invests in novel inhalable drug delivery platform
(Medial Release, 8 May 2009)

QRxPharma successfully completes comparative study for Dual-Opioid Pain Therapy
(Medial Release, 20 April 2009)

XeroCoat INC. announces Assembly and Test Worldwide INC. (ATW) as its auotmation partner for unique turnkey anit-reflective coating system
(Media Release, April 2009)

Uniseed Investment Powers Up Clean Technology Start-Up
(Medial Release, 31 March 2009)

$3m for promising new fibrosis drug

(Media Release, 9 February 2009)

Hatchtech $2.5m new funding for Phase II head lice trials

(Media Release, 8 December 2008)

Uniseed Investment Sells Semiconductor Technology Assets

(Media Release, 23 October 2008)

Spinifex Secures A$12m Investment to Develop Pain Drug
(Media Release, 3 September 2008)

Uniseed makes two further investments in University of Queensland Technologies

(Media Release, 19 August 2008)

FDA Accepts Streamlined Phase 3 Development Plan for QRx "Dual Opioid" Pain Therapy
Media Release, 5 August 2008)

XeroCoat Enters Solar Energy Market 
(Media Release, 7 July 2008)

QRx Pharma Releases Additional Phase 3 Data for "Dual Opioid" Pain Therapy
(Media Release, 22 May 2008)

BT Imaging Raises A$3 m Series A Funding
(Media Release, 19 May 2008)

QRx Pharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy
(Media Release, 5 May 2008)

 
 
© 2007 Uniseed Pty Ltd